Csenge Advisory Group Acquires Shares of 3,342 Express Scripts Holding Company (ESRX)

Csenge Advisory Group purchased a new position in Express Scripts Holding Company (NASDAQ:ESRX) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 3,342 shares of the company’s stock, valued at approximately $212,000.

Other institutional investors have also recently modified their holdings of the company. Burt Wealth Advisors lifted its stake in Express Scripts Holding by 11.4% in the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after acquiring an additional 174 shares during the last quarter. CKW Financial Group lifted its stake in Express Scripts Holding by 20.0% in the second quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after acquiring an additional 300 shares during the last quarter. IHT Wealth Management LLC lifted its stake in Express Scripts Holding by 8.1% in the first quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock worth $128,000 after acquiring an additional 145 shares during the last quarter. First Personal Financial Services lifted its stake in Express Scripts Holding by 199.1% in the second quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock worth $134,000 after acquiring an additional 1,400 shares during the last quarter. Finally, FNY Partners Fund LP purchased a new position in Express Scripts Holding in the first quarter worth approximately $138,000. Institutional investors own 90.30% of the company’s stock.

Express Scripts Holding Company (ESRX) opened at $60.54 on Monday. The stock has a market cap of $34,290.00, a PE ratio of 8.85, a price-to-earnings-growth ratio of 0.89 and a beta of 0.88. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. Express Scripts Holding Company has a 1-year low of $55.80 and a 1-year high of $77.50.

Express Scripts Holding (NASDAQ:ESRX) last released its earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $1.90. Express Scripts Holding had a net margin of 3.64% and a return on equity of 25.46%. The company had revenue of $24.68 billion for the quarter, compared to analyst estimates of $25.68 billion. During the same period in the prior year, the firm earned $1.74 EPS. The firm’s quarterly revenue was down 2.9% on a year-over-year basis. equities research analysts predict that Express Scripts Holding Company will post 7.01 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.com-unik.info/2017/11/06/csenge-advisory-group-acquires-shares-of-3342-express-scripts-holding-company-esrx.html.

A number of brokerages recently issued reports on ESRX. Jefferies Group LLC reiterated a “buy” rating on shares of Express Scripts Holding in a research note on Thursday, October 26th. Royal Bank Of Canada set a $66.00 price target on shares of Express Scripts Holding and gave the stock a “hold” rating in a research note on Wednesday, October 25th. Robert W. Baird lifted their price target on shares of Express Scripts Holding from $57.00 to $59.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 25th. Mizuho set a $67.00 price target on shares of Express Scripts Holding and gave the stock a “hold” rating in a research note on Tuesday, October 24th. Finally, Zacks Investment Research cut shares of Express Scripts Holding from a “buy” rating to a “sell” rating in a report on Tuesday, October 24th. Seven analysts have rated the stock with a sell rating, ten have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $69.53.

In other news, VP Everett Neville sold 1,163 shares of the company’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the transaction, the vice president now owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Phyllis S. Anderson sold 643 shares of the company’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total transaction of $40,103.91. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,284 shares of company stock valued at $397,421. Corporate insiders own 0.68% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

What are top analysts saying about Express Scripts Holding Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Express Scripts Holding Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit